Regenerative Product Development Series
Tom Koshy, PhD
Sr. Director, Clinical Affairs Medline Industries, LP
Thursday, April 6, 2023
Chronic Wound Management
Wound healing is a routine, but complex, physiological process that must rebuild tissue lost during an injury and restore the protective skin barrier, all while preventing infection other debilitating complications. While most wounds heal with little or no intervention, some wounds resist healing and become chronic. Chronic wounds require specialized and challenging medical care.
The objectives of this presentation are to 1) review the three general categories of wounds, 2) walk through the phases of normal wound healing, 3) describe the characteristics and categories of chronic, hard to heal wounds and 4) explore some of commercial products, generically described as skin substitutes, and strategies that can be used to re-start the healing process of chronic wounds.
Thomas Koshy is Senior Director of Clinical Affairs at Medline Industries, LP, where he is responsible for clinical strategy, coordination of Clinical Affairs and Compliance activities, integration of Clinical Affairs with Medical Affairs projects, maintenance of critical Clinical Affairs procedures and policies and Clinical Affairs personnel and team management. Dr. Koshy earned his Ph.D. in Biochemistry, Molecular Biology and Cell Biology from Northwestern University, and his BA in Biology from Kalamazoo College. Prior to working at Medline, he has held positions at Precision Xtract, The Binding Site, Alere, Inc., Biosite/Alere, and Abbott Diagnostics.
Caralynn Nowinski Collens
Thursday, January 27th, 2021
From technology to product to market
Dr. Collens will offer a perspective on what it takes to advance the development and commercialization of regenerative engineering products for medical applications. Drawing on her experiences building Dimension Inx and advising other startups, she will illustrate the journey from the lab to the market. She will also discuss the role of industry and investors in getting these types of products to market.
Dr. Caralynn Nowinski Collens is the CEO of Dimension Inx, a next-generation biomaterials and biofabrication company developing 3D-printed therapeutic products that direct cells to rebuild healthy tissues. She is passionate about building teams and organizations that harness technology to drive transformational change and improve the quality of people’s lives.
Previously as the co-founder and CEO of UI LABS, a first-of-its-kind technology organization focused on the digital future of industries, Caralynn built the organization from concept in late 2011 through launch in 2014, raising $200M+ in investment and ultimately spinning out MxD (national digital manufacturing institute) and City Tech Collaborative as independent businesses in 2019. After starting her first company while a joint medical/business student at the University of Illinois at Chicago, Caralynn spent her early career in venture capital and corporate finance, primarily focused on technology-based university spin-outs.
Caralynn is an Independent Director of Fathom Digital Manufacturing [NYSE:FATH] and serves on the Executive Council of Granite Creek Capital Partners. She is proud to have been a member of the Chicago Chapter of the Young Presidents’ Organization (YPO) and recognized as one of Crain’s Chicago Business’ “Forty Under Forty”, “Notable Women in Manufacturing”, and “Tech 50”. In 2020, SME recognized Caralynn as one of “30 Leaders Transforming Manufacturing”.
This seminar is a collaborative offering from the Center for Advanced Regenerative Engineering and the Department of Biomedical Engineering